You are viewing: UK Brain Monitoring Market analysis
Part of: Brain Monitoring Market (Global)

The UK Brain Monitoring Market was valued at $138.4 Million in 2023 and projected to reach to $204.8 Million by 2028, representing a compound annual growth rate of 8.2%. The UK brain monitoring market is positioned for sustained growth through 2028, supported by NHS commitment to neurology services and increasing clinical adoption of advanced monitoring technologies.

UK Brain Monitoring Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Brain Monitoring Market Trends and Insights

  • The UK's advanced healthcare infrastructure and increasing prevalence of neurological disorders are driving demand for sophisticated brain monitoring technologies.
  • The UK market benefits from strong NHS investment in neurology services and growing adoption of non-invasive monitoring devices across hospitals and diagnostic centres. In the UK, brain monitoring solutions are increasingly integrated into clinical workflows for conditions including epilepsy, sleep disorders, and neurodegenerative diseases.
  • The UK's regulatory environment, governed by the MHRA, supports rapid innovation and market entry for novel monitoring devices.
  • Between 2023 and 2028, the UK is expected to see significant expansion in portable and wearable brain monitoring technologies, driven by both private healthcare providers and NHS trusts seeking cost-effective patient management solutions..

Key Market Statistics

  • CAGR (2023-2028) 8.2% CAGR
  • Market Size, 2023 ~USD 138.4 Million
  • Forecast, 2028 ~USD 204.8 Million
  • Country UK

UK Brain Monitoring Market Overview

Strong Market Growth :

The UK brain monitoring market is expanding at 8.2% CAGR, outpacing the global rate of 6.3%, driven by NHS investment in neurology services and rising neurological disorder prevalence.

Advanced Healthcare Infrastructure :

The UK's sophisticated healthcare system and established medical device regulatory framework create a favorable environment for innovative brain monitoring technology adoption and deployment.

Neurological Disease Burden :

Increasing prevalence of conditions such as epilepsy, Parkinson's disease, and dementia across the UK population is driving demand for continuous and non-invasive brain monitoring solutions.

Market Valuation Trajectory :

The market is projected to grow from £138.4 million in 2023 to £204.8 million by 2028, representing a 48% increase in market value over the five-year forecast period.

UK Brain Monitoring Market Dynamics

  • Key drivers include rising incidence of neurological disorders, aging population demographics, and growing investment in digital health infrastructure.
  • The market will benefit from regulatory support for medical device innovation and strong healthcare spending priorities.
  • Emerging technologies such as wearable EEG devices and AI-powered diagnostic tools are expected to accelerate market expansion.
  • Competition among established medical device manufacturers and emerging healthtech companies will drive innovation and improve accessibility of brain monitoring solutions across UK healthcare settings..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • The UK brain monitoring market is valued at £138.4 million in 2023 and will reach £204.8 million by 2028, growing at 8.2% CAGR.
      • The UK's NHS investment and advanced healthcare infrastructure are primary drivers of market expansion in brain monitoring technologies.
      • Wearable and portable brain monitoring devices are gaining traction across the UK's private and public healthcare sectors.
      • The UK's MHRA regulatory framework enables faster innovation cycles and market entry for novel neurological monitoring solutions.

      Brain Monitoring Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment CEREBRAL OXIMETERS (Type)
      Forecast Period 2023–2028
      Growth Rate CAGR of 6.3% from 2023 to 2028
      Largest Segment NON-INVASIVE PROCEDURES (Procedure)
      Market Size Base Year (Billions) ~USD 3.54 (2023)
      Revenue Forecast (Billions) ~USD 4.8 (2028)
      Segments Covered Product, Type, Usability, Procedure, Modality, Medical Condition, End User

      UK Brain Monitoring Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Devices

      By Type

      • Batteries
      • Cables
      • Caps
      • Cerebral Oximeters
      • Ct Scanners
      • Dry Electrodes
      • Eeg Devices
      • Electrodes
      • Emg Devices
      • Icp Monitors
      • Meg Devices
      • Mri Scanners
      • Needle Electrodes
      • Other Accessories
      • Pastes & Gels
      • Pet Scanners
      • Sensors
      • Sleep Monitoring Devices
      • Tcd Devices
      • Wet Electrodes

      By Usability

      • Disposable Accessories
      • Non- Disposable Accessories
      • Non-Disposable Accessories

      By Procedure

      • Invasive Procedures
      • Non-Invasive Procedures

      By Modality

      • Fixed Devices
      • Portable Devices
      • Wearable Devices

      By Medical Condition

      • Dementia
      • Epilepsy
      • Headache Disorders
      • Huntington'S Disease
      • Other Medical Conditions
      • Parkinson'S Disease
      • Sleep Disorders
      • Stroke
      • Traumatic Brain Injury

      By End User

      • Ambulatory Surgery Centers & Clinics
      • Diagnostic Centers
      • Diagnostic Centres
      • Hospitals
      • Neurological Centers
      • Neurological Centres
      • Other End Users

      UK: BRAIN MONITORING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      AMBULATORY SURGERY CENTERS & CLINICS15.917.419.421.323.425.628.130.79.6
      DIAGNOSTIC CENTRES77.58.49.11010.811.812.88.9
      HOSPITALS88.795.4105113.6123.2133143.5154.68
      NEUROLOGICAL CENTRES29.632.436.440.144.348.853.758.910.1
      OTHER END USERS12.713.514.615.616.717.718.9206.5
      TOTAL153.9166.2183.7199.7217.6236256277.18.6

      Target Audience

      • Medical Device Manufacturers : Companies developing brain monitoring technologies need UK market data to assess market size, growth potential, competitive positioning, and NHS procurement requirements for product launches and expansion strategies.
      • Healthcare Investors & PE Firms : Investment professionals require detailed UK market analysis to evaluate investment opportunities in brain monitoring companies, assess market attractiveness, and identify acquisition targets within the British healthcare sector.
      • NHS Trusts & Hospital Networks : Healthcare procurement teams need market intelligence to benchmark brain monitoring technology options, understand pricing trends, evaluate vendor capabilities, and make informed purchasing decisions for neurology departments.
      • Pharmaceutical & Biotech Companies : Organizations developing neurological treatments require UK brain monitoring market data to understand diagnostic infrastructure, identify partnership opportunities, and support clinical trial recruitment and patient monitoring.
      • Healthcare Consultants & Strategy Firms : Consulting professionals advising healthcare organizations and medical device companies need UK-specific market research to develop market entry strategies, competitive analyses, and business development recommendations.

      Key Companies in the UK Brain Monitoring Market

      CompanyHQOwnershipStrongest segments
      CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic and Sports Medicine (BioBrace, Y-Knot, Hall power tools, arthroscopy ecosystem),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic Technologies and Patient Monitoring,
      NATUS MEDICAL INCORPORATEDUnited StatesPrivate CompanyNeurodiagnostic systems (EEG, EMG, ICU monitoring, polysomnography, intra-operative monitoring),Newborn care (hearing screening, jaundice management, brain injury, NICU essentials, NICVIEW),Audiology, otoneurologic, and vestibular systems,
      NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and related),Defibrillators, AEDs, ventilators, anesthesia and related devices,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      COMPUMEDICS LIMITEDAustraliaPublic CompanySleep diagnostics (PSG, HST, Somfit),Neurology diagnostics (EEG, LTM, ambulatory),Brain research & MEG systems,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Surgical, Monitoring, Diabetes),
      EDWARDS LIFESCIENCES CORPORATIONUnited StatesPublic CompanyTranscatheter aortic valve replacement (SAPIEN family),Transcatheter mitral and tricuspid (PASCAL, EVOQUE),Surgical structural heart (INSPIRIS, RESILIA, KONECT, MITRIS),
      CGXCanadaPublic CompanyFilm Entertainment and Content (theatrical, Event Cinema, food service),Media (on-screen, digital signage, advertising solutions),Location-Based Entertainment (Rec Room, Playdium, Junxion, in-theatre gaming),

      CONMED CORPORATION

      CONMED Corporation is a publicly traded U.S. medical device company founded in 1970 with approximately 3,900 employees.

      NATUS MEDICAL INCORPORATED

      Natus Medical Incorporated is a U.S.-based private company founded in 1987 with 1,400 employees specializing in medical devices and monitoring solutions.

      NIHON KOHDEN CORPORATION

      Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, operating in the medical device and healthcare technology industry.

      GE HEALTHCARE

      GE Healthcare is a publicly traded U.S. company established in 2022 with 54,000 employees, providing healthcare technology and solutions.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a German public company with roots dating to 1896 and 72,369 employees, operating as a global leader in medical technology and diagnostics.

      COMPUMEDICS LIMITED

      Compumedics Limited is an Australian publicly traded company founded in 1987 with 175 employees, specializing in medical device manufacturing.

      MEDTRONIC

      Medtronic is a publicly traded company founded in Ireland in 1949 with 95,000 employees, serving as a global leader in medical technology and healthcare solutions.

      EDWARDS LIFESCIENCES CORPORATION

      Edwards Lifesciences Corporation is a U.S. public company founded in 1958 with 16,000 employees, specializing in cardiovascular and critical care medical devices.

      CGX

      CGX is a Canadian public company founded in 1912 with 10,000 employees operating across multiple business sectors.

      Reasons to Buy this Report

      • UK-Specific Market Sizing : Obtain precise valuation data for the UK market (£138.4M in 2023) with detailed forecasts through 2028, enabling accurate budget allocation and market entry strategies tailored to the British healthcare landscape.
      • Competitive Intelligence : Understand the competitive dynamics specific to the UK market, including key players, market share distribution, and differentiation strategies among brain monitoring device manufacturers operating in British healthcare.
      • NHS Procurement Insights : Gain intelligence on NHS purchasing patterns, reimbursement pathways, and procurement requirements for brain monitoring technologies, critical for suppliers seeking to establish or expand presence in UK public healthcare.
      • Growth Opportunity Identification : Identify high-growth segments within the UK market, including emerging technologies, underserved clinical applications, and geographic regions with the highest adoption potential for brain monitoring solutions.
      • Regulatory and Market Access Strategy : Access UK-specific regulatory requirements, NICE approval processes, and market access pathways essential for launching brain monitoring products successfully in the British healthcare system.

      Frequently asked questions

      What is the current size of the UK brain monitoring market?

      The UK brain monitoring market was valued at £138.4 million in 2023 and is expected to grow to £204.8 million by 2028.

      What is the growth rate of the UK brain monitoring market?

      The UK brain monitoring market is projected to grow at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2028.

      Which technologies are driving growth in the UK brain monitoring market?

      Wearable devices, portable EEG systems, and non-invasive monitoring solutions are key technologies driving growth in the UK market.

      How is the UK NHS influencing the brain monitoring market?

      The UK NHS's investment in neurology services and adoption of advanced monitoring technologies across trusts is a major growth driver for the market.

      What regulatory body oversees brain monitoring devices in the UK?

      The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating brain monitoring devices in the UK.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

      Secondary Research

      This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the brain monitoring market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

      Some of the major objectives of primary research are:

      • To validate market segmentation defined through an assessment of the product portfolios of leading players
      • To understand the key industry trends and technologies defining the strategic growth objectives of market players
      • To gather both demand- and supply-side validation of the key factors affecting the market growth
      • To validate assumptions for the market sizing and forecasting model used for this study
      • To understand the market position of leading players in the brain monitoring market and their market share/ranking

      Breakdown Of Primary Participants

      Brain Monitoring Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2019, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Brain Monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

      Bottom-up approach

      The bottom-up procedure was adopted to arrive at the overall size of the Brain Monitoring market from the revenue of key players (companies), their shares in the market, and their annual sales of Brain Monitoring products.

      Brain Monitoring Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down approach

      The overall Brain Monitoring market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, medical condition, end user, and region) through percentage splits from secondary and primary research.

      For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

      Brain Monitoring Market Size, and Share

      Data Triangulation

      After arriving at the overall market size, from the market size estimation process explained above, the Brain Monitoring market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Brain Monitoring industry.

      Market Definition

      Brain Monitoring is a procedure that monitors the activity of various parameters associated with the functioning of brain, which includes electrical activity, blood flow, magnetic activity, the pressure surrounding the brain, and cerebral oxygen saturation.

      Key Stakeholders

      • World Health Organization (WHO)
      • National Center for Biotechnology Information (NCBI)
      • World Federation of Neurology (WFN)
      • Centers for Disease Control and Prevention (CDC)
      • Epilepsy Foundation
      • American Brain Foundation (ABF)
      • Brain Injury Association of America (BIAA)
      • Neurology Asia Journal
      • Alzheimer's Association
      • American Neurological Association (ANA)
      • European Journal of Neurology

      Report Objectives

      • To define, describe, and forecast the brain monitoring market based on the product, procedure, modality, medical condition, end user, and region.
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges).
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall brain monitoring market.
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
      • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
      • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
      • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

      Available Customizations:

      MarketsandMarkets offers the following customizations for this market report:

      Company Information

      • Profiling of additional market players (up to 3)
      • Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.

      Get the Full Brain Monitoring Market Report

      Full forecast, segment splits, and company analysis for all Brain Monitoring Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status